PAS
JAZZ icon

Park Avenue Securities’s Jazz Pharmaceuticals JAZZ Stock Holding History

Park Avenue Securities’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$869K Buy
+3,608
New +$790K 0.01% 1026
2026
Q1 		– Sell
-6,081
Closed -$1.03M – 1616
2025
Q4 		$1.03M Buy
6,081
+323
+6% +$49.5K 0.01% 795
2025
Q3 		$759K Buy
5,758
+2,593
+82% +$311K 0.01% 997
2025
Q2 		$336K Buy
+3,165
New +$344K ﹤0.01% 1235
2025
Q1 		– Sell
-2,521
Closed -$310K – 1366
2024
Q4 		$310K Buy
2,521
+412
+20% +$48.6K ﹤0.01% 1279
2024
Q3 		$235K Sell
2,109
-858
-29% -$94K ﹤0.01% 1282
2024
Q2 		$317K Sell
2,967
-36
-1% -$3.96K ﹤0.01% 1164
2024
Q1 		$362K Sell
3,003
-2,233
-43% -$274K ﹤0.01% 1095
2023
Q4 		$644K Sell
5,236
-292
-5% -$36.4K 0.01% 806
2023
Q3 		$716K Buy
+5,528
New +$737K 0.01% 698
2023
Q1 		– Sell
-3,100
Closed -$494K – 944
2022
Q4 		$494K Buy
3,100
+70
+2% +$10.3K 0.01% 781
2022
Q3 		$404K Sell
3,030
-993
-25% -$151K 0.01% 797
2022
Q2 		$628K Buy
4,023
+222
+6% +$34.2K 0.01% 624
2022
Q1 		$592K Buy
3,801
+1,119
+42% +$162K 0.01% 673
2021
Q4 		$342K Buy
2,682
+583
+28% +$76.6K 0.01% 870
2021
Q3 		$273K Sell
2,099
-678
-24% -$102K 0.01% 892
2021
Q2 		$493K Buy
2,777
+288
+12% +$49.9K 0.01% 639
2021
Q1 		$409K Buy
2,489
+446
+22% +$73.4K 0.01% 647
2020
Q4 		$337K Sell
2,043
-890
-30% -$133K 0.01% 636
2020
Q3 		$418K Sell
2,933
-317
-10% -$39.3K 0.01% 470
2020
Q2 		$359K Buy
3,250
+365
+13% +$40.4K 0.01% 462
2020
Q1 		$288K Buy
2,885
+1,164
+68% +$150K 0.02% 243
2019
Q4 		$257K Buy
+1,721
New +$234K 0.01% 506

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Park Avenue Securities's JAZZ Position: Q2 2026 in Review

Park Avenue Securities opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 3,608 shares worth $869K. The stake represents 0.01% of the portfolio and ranks #1026 among its holdings. This is a return to the name: Park Avenue Securities previously reported a position in JAZZ as recently as Q4 2025.

Park Avenue Securities first reported a position in JAZZ in Q4 2019 and has held it in 23 quarters since. The position peaked at $1.03M in Q4 2025. 72 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Park Avenue Securities held 3,608 shares of Jazz Pharmaceuticals worth $869K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Park Avenue Securities position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1026 holding.
  • Park Avenue Securities first reported a position in Jazz Pharmaceuticals in Q4 2019 and has held it in 23 quarters since.
  • Park Avenue Securities's Jazz Pharmaceuticals position peaked at $1.03M in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.